ArticleAngewandte Chemie (International ed. in English)2026
Extended Fused Carbazole-BODIPY, High Brightness NIR Organic Dyes.
Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pyrazine-embedded N^N^N-chelating tetracoordinate organoboron polycyclic heteroaromatics with low-lying LUMO levels and near-infrared luminescence.Chemical science · 2026Article
- Naphthalimide-fused BODIPYsChemical science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Fluorescence-based bioimaging enables noninvasive visualization of molecular and cellular processes with high sensitivity and without ionizing radiation. However, conventional fluorophores emitting in the visible or near-red infrared I (NIR-I) (650-800 nm) regions suffer from limited tissue penetration and scattering. Extending fluorescence emission into the deeper NIR region represents a promising strategy to overcome these drawbacks, yet achieving high brightness and stability in organic dyes remains a major challenge. We report an original family of hetero-substituted-fused boron-dipyrromethene (BODIPY) dyes bearing carbazole and thienyl donors that exhibit record brightness and emission maxima up to 852 nm in toluene. The synthetic route combines successive Stille couplings from a 2,6-dibromo-3,5-diiodo-BODIPY precursor and an unprecedented silver(I)-mediated oxidative cyclization, affording high yields and suppressing undesired chlorination. The resulting dyes display intense absorption (ε = 1.8-2.5 × 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.